Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001085146-22-004203
Filing Date
2022-11-25
Accepted
2022-11-23 17:52:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 NORFIELD CAPITAL, LLC ocx_112322.htm SC 13G 25823
  Complete submission text file 0001085146-22-004203.txt   27480
Mailing Address 47 LOIS STREET NORWALK CT 06851
Business Address 47 LOIS STREET NORWALK CT 06851 203-642-3490
Norfield Capital LLC (Filed by) CIK: 0001639907 (see all company filings)

EIN.: 352524540 | State of Incorp.: CT | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Subject) CIK: 0001642380 (see all company filings)

EIN.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89221 | Film No.: 221417267
SIC: 2835 In Vitro & In Vivo Diagnostic Substances